Does UnitedHealthcare Cover Cialis? Formulary Status, Costs, and Alternatives

The Short Answer Depends on Your Exact UHC Plan

UnitedHealthcare administers many commercial, employer, individual, Medicare Advantage, and Part D benefits. Employers can also customize pharmacy coverage. A drug's status in one UHC document therefore does not establish its status in another member's plan.

Official UHC formularies illustrate the variation:

• A UHC Group Medicare Advantage drug list for 2026 lists generic tadalafil 2.5 mg and 5 mg on Tier 1 with prior authorization and a quantity limit of one tablet per day. It lists brand Cialis 5 mg on Tier 3 with the same types of restrictions [1].
• A 2025 UHC Advantage 3-Tier commercial drug list placed oral generic tadalafil on Tier 2 with a quantity limit and marked brand Cialis as excluded [2].
• A 2025 Illinois individual-plan update excluded tadalafil 10 mg and 20 mg from the referenced prescription drug list [3].

These are examples, not promises about another plan. They also show why a statement such as "UHC covers tadalafil" is incomplete without the plan name, benefit year, strength, and indication.

How to Check Your Actual Coverage

Use the drug-pricing or formulary tool inside your UnitedHealthcare member account. UHC advises members to review their current Prescription Drug List and pharmacy network through their plan resources [4].

Search each of the following separately:

1. Generic name: tadalafil
2. Brand name: Cialis
3. Exact strength: 2.5 mg, 5 mg, 10 mg, or 20 mg
4. Exact dosing pattern: once daily or as needed
5. Reason for treatment: erectile dysfunction (ED), benign prostatic hyperplasia (BPH), or another diagnosed condition

For every result, check:

• covered, nonformulary, or excluded status
• formulary tier and whether a deductible applies
• prior authorization (PA)
• quantity limit (QL)
• step therapy (ST)
• preferred or in-network pharmacy rules
• retail, home-delivery, and days-supply options

The most reliable confirmation is a live pharmacy test claim. A pharmacist or the member-services number on the insurance card can identify the exact rejection code, if any. Do not rely on a search-engine snippet or a formulary from a different year.

Coverage for Erectile Dysfunction

Tadalafil is FDA approved for erectile dysfunction. The current U.S. prescribing information describes an as-needed starting dose of 10 mg that may be adjusted based on response and tolerability, as well as once-daily dosing that starts at 2.5 mg and may increase to 5 mg [5]. The American Urological Association guideline includes PDE5 inhibitors such as tadalafil among treatment options that clinicians should discuss with appropriate patients [6].

Commercial coverage still varies. A plan may cover generic tadalafil, exclude the brand, restrict the quantity, require prior authorization, or exclude ED drugs altogether. There is no evidence-based universal UHC copay, monthly tablet allowance, step-therapy sequence, or PA turnaround time across all of these plans.

Medicare Part D and ED

Medicare's prescription-drug rules generally exclude drugs when they are used for erectile dysfunction. CMS also explains that the same drug can qualify as a Part D drug when prescribed for a different, medically accepted indication that is not subject to the ED exclusion; a plan may separately offer supplemental coverage [7].

That distinction is about the actual condition being treated. It is not permission to submit BPH or another diagnosis solely to obtain coverage for ED. The prescription, claim, and clinical record must be truthful.

Coverage for Benign Prostatic Hyperplasia

The current tadalafil label includes treatment of the signs and symptoms of BPH, as well as combined ED and BPH. The labeled once-daily dose for BPH is 5 mg [5]. Randomized trial evidence also supports improvement in BPH symptom scores with once-daily tadalafil, although clinical suitability is an individual decision [8].

Because BPH is a non-ED indication, the Medicare ED exclusion is not automatically the end of the coverage analysis. But FDA approval does not force every Part D formulary to cover every product. The member's plan may still apply formulary, prior-authorization, quantity-limit, and pharmacy-network rules.

If a person has both ED and BPH, the prescriber should document the conditions actually diagnosed and choose treatment on clinical grounds. A website, pharmacy, or patient should not choose an inaccurate billing code.

Pulmonary Arterial Hypertension Is a Separate Coverage Path

Tadalafil is also used in a different product and dosing context for pulmonary arterial hypertension (PAH). The PHIRST randomized trial evaluated tadalafil for PAH and found improved exercise capacity at the studied 40 mg dose [9]. UHC's current commercial pharmacy program lists tadalafil PAH products among therapies subject to its PAH prior-authorization and medical-necessity program [10].

An ED/BPH tadalafil listing does not establish coverage for PAH, and a PAH listing does not establish coverage for Cialis used for ED. Members with PAH should use the product-specific specialty-drug process identified by their plan and treating specialist.

What Prior Authorization or a Quantity Limit Means

A formulary entry can be covered and still carry restrictions:

• Prior authorization: the plan requires specified clinical information before it will pay.
• Quantity limit: the plan limits the amount covered during a stated period.
• Step therapy: the plan requires a covered alternative first, unless its criteria allow an exception.
• Excluded or nonformulary: the standard benefit does not cover that product, although a formulary exception may be available under some plans.

The required documentation is defined by the member's plan. Do not assume every request needs testosterone testing, specialist prescribing, a particular age, or a trial of sildenafil. Those requirements were previously stated on this page without a plan-specific policy and have been removed.

What Tadalafil Will Cost

There is no reliable UHC-wide copay range. A member's price can change with:

• the exact plan and formulary tier
• brand versus generic dispensing
• deductible status and coinsurance
• tablet strength and covered quantity
• retail versus home-delivery benefits
• preferred versus nonpreferred pharmacy
• whether the claim is paid by insurance or purchased for cash

Compare the member-account price with the pharmacy's live adjudicated claim. If considering a cash price, ask whether that purchase will count toward the plan deductible or out-of-pocket maximum; cash transactions commonly sit outside the insurance claim. Discount-card terms also vary, and they generally cannot be combined with an insurance claim for the same fill.

What to Do If UnitedHealthcare Denies the Claim

Start with the exact denial reason rather than sending a generic appeal. Common categories include:

• the drug or strength is excluded
• prior authorization is required or incomplete
• the quantity exceeds the plan limit
• the refill is too soon
• the pharmacy is outside the network
• the submitted product or National Drug Code is not covered
• the indication does not meet the plan's criteria
• Medicare's ED exclusion applies

Ask the pharmacist for the rejection message and obtain the written coverage determination or denial notice. The notice should identify the next step, deadline, and where to send records. Appeal procedures differ among commercial plans, self-funded employer plans, and Medicare drug plans, so a universal 180-day deadline or success rate would be misleading.

A useful request from the prescriber should respond to the actual criterion and use accurate medical records. Depending on the denial, options may include correcting a clerical error, completing PA questions, requesting a quantity-limit or formulary exception, using a covered generic, or choosing another clinically appropriate therapy. The prescriber, not the insurer's tier alone, should determine whether an alternative is medically appropriate.

Important Tadalafil Safety Information

Coverage does not establish that tadalafil is safe for a particular person. The prescribing information states that tadalafil is contraindicated with nitrates and with guanylate cyclase stimulators because of the risk of dangerous blood-pressure lowering [5]. Patients should tell the prescriber about alpha-blockers, blood-pressure medicines, kidney or liver disease, heart disease, and all other ED or PAH medicines.

Seek urgent medical care for an erection lasting more than four hours, sudden vision or hearing loss, chest pain, or other severe symptoms. A person who develops chest pain after taking tadalafil should tell emergency clinicians when it was last taken and should not self-administer a nitrate.